If you are like me, you may not be in the position to buy a house today for a variety of reasons. That is unfortunate because the real estate market is set up to be one of those outperforming sectors over the next several years. Interest rates are low relative to historical measures and home prices are still affordable relative to local rental rates.
So that brings us to the investment thesis: in an environment where cheap and fixed rate interest debt is becoming easier for consumers/investors to obtain and where inflation and rental rates are likely to rise, the natural asset class to own is real estate.
Of course, there are many ways to play real estate: homebuilders, home and mortgage insurers, mortgage lenders and ancillary plays such as home furnishers, home improvement retailers, and so forth. However, the most attractive way to play an improving real estate market in my opinion, is simply to own it. One can either own it directly through buying property (and managing or living in it), or indirectly through owning stock of public companies whose primary business is owning/operating real estate assets.
Top 5 Beverage Stocks To Invest In Right Now: Hawaiian Holdings Inc.(HA)
Hawaiian Holdings, Inc., through its subsidiary, Hawaiian Airlines, Inc., engages in the scheduled air transportation of passengers and cargo. It offers daily service on transpacific routes between Hawaii and Los Angeles, Oakland, Sacramento, San Diego, San Francisco, and San Jose, California; Las Vegas, Nevada; Phoenix, Arizona; Portland, Oregon; and Seattle, Washington, as well as daily service on its inter island routes among the four islands of the State of Hawaii. The company also provides scheduled service on its Pacific routes between Hawaii and Pago Pago, American Samoa; Papeete, Tahiti; Sydney, Australia; Manila, Philippines; Tokyo, Japan; and Seoul, South Korea, as well as other ad hoc charters. As of December 31, 2010, its fleet consisted of 15 Boeing 717-200 aircraft for its interisland routes; 18 Boeing 767-300; and 3 Airbus A330-200 aircrafts for its transpacific, Pacific, and charter routes. Hawaiian Holdings, Inc. was founded in 1929 and is headquartered in Honolulu, Hawaii.
Advisors' Opinion:- [By Ben Levisohn]
DeNardi also rates Alaska Air (ALK), Spirit Airlines (SAVE) and Allegiant Travel (ALGT) as Buys and Southwest, JetBlue Airways (JBLU) and Hawaiian Holdings (HA) as holds.
- [By Adam Levine-Weinberg]
Earlier this month, Allegiant announced a new route that marks a significant shift in the company's philosophy. Beginning in late October, Allegiant will serve the busy Los Angeles-Honolulu route twice a week. This route is already served by all three major network carriers, as well as Hawaiian Airlines (NASDAQ: HA ) , with each carrier offering multiple daily flights. What is Allegiant up to? More importantly, will it work?
- [By Rich Smith]
Following up on January's announcement that Hawaiian Airlines (NASDAQ: HA ) is buying 16 new A321neo airliners from Airbus -- and optioning nine more -- airplane engine maker United Technologies (NYSE: UTX ) said Thursday that it will be supplying the engines for all 25 airplanes.
- [By Ben Levisohn]
Last week Hawaiian Airlines (HA) announced they will suspend service from Honolulu to Fukuoka after two years of unprofitable service. Hawaiian stated the market was not profitable. Delta recently started flying Honolulu-Fukuoka (and they have hedged the Yen at 80); both US airlines were operating about half full. As a result of Hawaiian leaving the market, we expect Delta’s load factors to improve. Delta has been slowly overlaying a lot of competitor capacity on the West Coast, especially to / from Seattle…
Best Performing Companies To Invest In Right Now: Prumo Logistica SA (LLXL3)
Prumo Logistica SA, formerly LLX Logistica SA (LLX), is a Brazil-based company primarily engaged in the sector of port logistic services. The Company builds and develops the Acu Port, located in Sao Joao da Barra, in the north of the State of Rio de Janeiro. The Industrial Complex Acu Port has two port terminals (T1 and T2) and the capacity to handle various types of cargo, such as petroleum, iron ore, coal, solid and liquid bulk and general cargo. The Company�� subsidiaries include LLX Minas-Rio Logistica Comercial Exportadora SA, LLX Acu Operacoes Portuarias SA and LLX Brasil Operacoes Portuarias SA. In October, 2013, EIG LLX Holdings SARL reached a 52.82% stake in the ordinary share capital of the Company. Advisors' Opinion:- [By Denyse Godoy]
A committee of exchange executives, banks and brokerages developed the changes to the benchmark index. BM&FBovespa said on its website that it hadn�� made changes to the gauge�� methodology since its inception in 1968. LLX Logistica SA (LLXL3), the shipping unit that Batista founded, is the second-lowest priced stock on the Ibovespa after dropping 36 percent this year to 1.53 reais.
Best Performing Companies To Invest In Right Now: Clean Diesel Technologies Inc.(CDTI)
Clean Diesel Technologies, Inc. engages in the manufacture and distribution of emissions control systems and products for heavy duty diesel and light duty vehicle markets. The company operates in two divisions, Heavy Duty Diesel Systems and Catalyst. The Heavy Duty Diesel Systems division designs and manufactures verified exhaust emissions control solutions that are used to reduce exhaust emissions created by on-road, off-road, and stationary diesel and alternative fuel engines, including propane and natural gas. Its products include closed crankcase ventilation systems, diesel oxidation catalysts, diesel particulate filters, Platinum Plus fuel-borne catalysts, ARIS selective catalytic reduction reagents, catalyzed wire mesh diesel particulate filters, alternative fuel products, and exhaust accessories. This division offers its products for original equipment manufacturers of heavy duty diesel equipment, such as mining equipment, vehicles, generator sets, and construction equipment, as well as retrofit customers consisting of school districts, municipalities, and other fleet operators. The Catalyst division produces catalyst formulations using its proprietary MPC technology for gasoline, diesel, and natural gas induced emissions. Its products comprise catalysts for gasoline engines, diesel engines, and energy applications. This division supplies its catalysts to automotive manufacturers and large heavy duty diesel engine manufacturers. The company sells its products through a network of distributors and dealers, and its direct sales force worldwide. Clean Diesel Technologies, Inc. is based in Ventura, California.
Advisors' Opinion:- [By James E. Brumley]
Did you miss today's 123% pop from Clean Diesel Technologies, Inc. (NASDAQ:CDTI)? If you didn't chase it higher after the bullish gap left behind at the open, then good for you - you made the right choice. As tempting as CDTI looked then (and still does), the bulk of any near-term gain here has already been realized, and there's no real point in jumping on the bandwagon now. Fear not if you missed the big move from Clean Diesel Technologies though. There's another, smaller name playing the same game, and you won't have to pay a fortune for it just to take a big risk.
- [By Paul Ausick]
One Nasdaq stock posting outsized gains today is Clean Diesel Technologies Inc. (NASDAQ: CDTI) which is getting a share price boost of 68.85%. The company announced that it will begin shipping emissions control systems��catalysts to Honda in the first half of this year. The stock will close at around $4.82 in a 52-week range of $1.10 to $7.39 (the high was set today and was nearly double Monday�� closing price of $2.83). Volume was about 36-times the daily average of around nearly 525,000 shares traded.
- [By CRWE]
Clean Diesel Technologies, Inc. (Nasdaq:CDTI), a cleantech emissions control company, will be a presenter at the 3rd Annual Craig-Hallum Capital Group Alpha Select Conference. The presentation is scheduled for 2:10 p.m. ET on Thursday, September 27, 2012 at the Sentry Centers in New York.
- [By Bryan Murphy]
Look out Clean Diesel Technologies, Inc. (NASDAQ:CDTI), and Cummins Inc. (NYSE:CMI), you may want to take notice too. Little HydroPhi Technologies Group, Inc. (OTCMKTS:HPTG) is about to make a big splash in your pool, which could make life very difficult and much easier (respectively) for the two of you. How's that? In simplest terms, all signs point to HydroPhi Technologies' diesel efficiency working quite well, saving those who use it money, while simultaneously saving the environment.
Best Performing Companies To Invest In Right Now: BioTime Inc (BTX)
BioTime, Inc., incorporated on November 30, 1990, is a biotechnology company focused on the emerging field of regenerative medicine. Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (hES) cell lines, and royalties from Hextend. Its focus is to provide regenerative therapies for age-related degenerative diseases. In January 2011, the Company acquired the assets of Cell Targeting, Inc. (CTI), a biotechnology company focused on methods of painting molecules on the surface of cells, which in turn causes the cells to adhere to particular tissues, such as those afflicted with disease. On March 21, 2011, the Company acquired Glycosan BioSystems, Inc. (Glycosan) through a merger of Glycosan with OrthoCyte Corporation (OrthoCyte). Through the merger, OrthoCyte acquired all of Glycosan�� assets, including Glycosan�� Hystem hydrogel product line. In March 2011, the Company entered into an agreement with XenneX, Inc., pursuant to which it organized LifeMap Sciences, Inc. (LifeMap), a subsidiary formed to advance the development and commercialization of its human embryonic stem (hES) cell data base. In August 2011, four hES cell lines (ESI-035, ESI-049, ESI-051 and ESI-053) developed by its subsidiary ES Cell International (ESI) were approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry. In May 2012, the Company acquired XenneX, Inc., through a merger of XenneX into LifeMap Sciences. In September 2012, the Company formed a wholly owned subsidiary, BioTime Acquisition Corporation. In October 2013, Geron Corporation announced the closing of the transaction to divest the Company's stem cell assets to Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc.
HyStem is a biomaterial, which mimics the human extracellular matrix, which is the network of molecules surrounding cells in organs and tissues which is essent! ial to cellular function. Its HyStem hydrogels may have other applications when combined with the diverse and scalable cell types its scientists have isolated from hES cells. HyStem-Rx is a clinical grade formulation of HyStem-C, a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. Its subsidiary, OncoCyte Corporation, is developing PanC-Dx, a non-invasive blood-based cancer screening test designed to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check -ups. BioTime Asia, Limited (BioTime Asia) sells products for research use and may develop therapies to treat cancer and neurological and orthopedic diseases in Asia. OrthoCyte Corporation (OrthoCyte) is developing therapies to treat orthopedic disorders, diseases and injuries. ReCyte Therapeutics, Inc. (ReCyte Therapeutics) is developing therapies for age-related cardiovascular and blood disorders. Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences), is a biotechnology company focused on developing stem cell-based therapies for retinal and other neurological disorders, including the development of retinal pigment epithelial (RPE) cells for the treatment of age-related macular degeneration. LifeMap Sciences, Inc. (LifeMap) is advancing the development and commercialization of our embryonic stem cell database and plans to make the database available for the marketing of research products and for use by stem cell researchers at pharmaceutical and biotechnology companies and other institutions via paid subscriptions or on a fee per use basis.
The Company�� blood plasma expander product, Hextend, is a physiologically balanced intravenous solution used in the treatment of hypovolemia, a condition caused by low blood volume, often from blood loss during surgery or injury. Hextend maintains circulatory system fluid volume and blood pressure, and keeps vital organs perfused during surgery and t! rauma car! e. Hextend is manufactured and distributed in the United States by Hospira, Inc., and in South Korea by CJ CheilJedang (CJ), under license from it.
Human Embryonic Stem Cell Lines for Research Use
Combined with the Company�� ACTCellerate technology, it derives of a range of markets human embryonic progenitor cells (hEPCs). ESI�� six current good manufacturing practices (cGMP) hES cell lines have been approved by the NIH for inclusion in the Human Embryonic Stem Cell Registry, which renders those cell lines eligible for use in federally funded research. The ESI hES cell lines are available for purchase through www.biotimeinc.com. It also markets hEPCs developed using ACTCellerate technology. Its hEPCs are also available for sale through www.biotimeinc.com. It derived the complete genome sequence of five of the ESI hES cell lines to facilitate the development of products derived from these cell lines. It has made these GMP-grade cell lines, along with certain documentation and complete genomic deoxyribonucleic acid (DNA) sequence information, available for sale.
The Company offers human stem cell products and technology that can be used by researchers at universities and at companies in the bioscience and biopharmaceutical industries. It has developed research and clinical grade hES cell lines, which it markets for both basic research and therapeutic product development. It also markets human embryonic progenitor cell (hEPCs) developed using ACTCellerate technology. These hEPCs are purified lineages of cells, which are intermediate in the developmental process between embryonic stem cells and fully differentiated cells. The ACTCellerate cell lines are also available for purchase through http://www.biotimeinc.com.
Human Embryonic Progenitor Cells
Through the Company�� subsidiary ReCyte Therapeutics, it had a license from Advanced Cell Technology, Inc. (ACT) to use ACTCellerate technology, and the rights to market more than 200 human c! ell types! made using that process. ACTCellerate allows the rapid isolation of hEPCs, which are cells that are intermediate in the developmental process between embryonic stem cells and fully differentiated cells.
Through an agreement with ReCyte Therapeutics, Millipore Corporation became a global distributor of ACTCellerate hEPC lines. In addition to the products, which it is co-marketing with Millipore, it offers 92 other ACTCellerate hEPC lines for purchase at www.biotimeinc.com. Through its subsidiary LifeMap, it provides online biomedical database services to increase awareness of molecular markers and diverse cell types comprising its ACTCellerate hEPC lines. It also focuses to market additional cell types manufactured with its PureStem technology. PureStem cell lines are produced by the exogenous expression of specific transcription factors, which regulate the differentiation of cell types from hES or induced pluripotent stem (iPS) cells. BioTime Asia has an agreement with Shanghai Genext Medical Technology Co., Ltd. to sell ACTCellerate hEPC lines and related ESpan growth media to the medical and biological research communities in China, Taiwan, Hong Kong, and Macau on an exclusive basis. The marketing agreement includes provisions for an initial stocking inventory and annual milestones to maintain exclusivity. The Company�� California Institute of Regenerative Medicine (CIRM)-funded research addresses the need for industrial scale production of purified therapeutic cells.
hES Cells Carrying Genetic Diseases
The Company focuses to add to its product line muscle progenitor cells produced from five hES cell lines carrying genes for Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, spinal muscular atrophy Type I, facioscapulohumeral muscular dystrophy 1A, and Becker muscular dystrophy. It obtained the diseased hES cell lines from Reproductive Genetics Institute (RGI).
ESpan Cell Growth Media
The Company is marketing a range of! cell-gro! wth media products called ESpan. These growth media are optimized for the growth of hEPC types. Cells need to be propagated in liquid media, in both the laboratory setting, where basic research on stem cells is performed, and in the commercial sector. Its ESpan products are marketed through Millipore and Genext.
ESpy Cell Lines
The Company focuses for development of ESpy cell lines. The ability of the ESpy cells to emit light will allow researchers to track the location and distribution of the cells in both in vitro and in vivo studies.
HyStem Hydrogel for Research and HyStem-Rx for Cell Delivery Medical Devices
HyStem is a patented biomaterial that mimics the ECM, the network of molecules surrounding cells in organs and tissues that is essential to cellular function. Its HyStem technology forms the foundation for stem cell delivery products in both the adult and embryonic stem cell marketplace, including products manufactured using its ACTCellerate technology. As an injectable product, HyStem-Rx may address need in cosmetic and reconstructive surgeries and other procedures by transplanting adipose derived cells or other adult stem cells. The transfer of cells in HyStem-Rx localizes the transplanted cells at the intended site and by providing a three-dimensional scaffold upon which cells can rebuild normal tissue. HyStem-Rx may support other emerging cell and tissue transplant therapies, such as those derived from hES and iPS cells, in addition to its potential application in the treatment of a range of conditions such as osteoarthritis, brain tumors, stroke, bone fracture, and wounds.
Advisors' Opinion:- [By John Udovich]
Stem cell stocks have not exactly been the best performers lately in part because the controversy over their use has died down over the years while major breakthroughs have been few or far between, but the industry along with small cap stem cell stocks Pluristem Therapeutics Inc (NASDAQ: PSTI), BioTime, Inc (NYSEMKT: BTX) and BioRestorative Therapies (OTCBB: BRTX) are still quietly producing their share of news or minor breakthroughs worth taking note of. Just consider the following stem cell news or news from small cap players in the sector:
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company BioTime (NYSEMKT: BTX ) has received the dreaded one-star ranking.
Best Performing Companies To Invest In Right Now: Trex Company Inc.(TREX)
Trex Company, Inc. manufactures and distributes wood/plastic composite products, and related accessories primarily for the residential and commercial decking and railing applications in the United States. The company offers decking products, including Trex Transcend and Trex Enhance protective shells for protection against fading, staining, and scratching; Trex Accents that provides a smooth surface on one side and subtle wood grain on the other; Trex Escapes, a cellular PVC deck board; and Trex Hideaway, a hidden fastening system for specially grooved boards. It also provides railing products comprising Trex Designer Series Railing, which consists of a decorative top and bottom rail, refined balusters, and post caps and skirts; and Trex Transcend Railing for use with Trex decking products, as well as other decking materials. In addition, the company offers Trex Transcend Porch Flooring and Railing System, an integrated system of porch components and accessories; and fenci ng products, such as Trex Seclusions fencing product that uses interlocking pickets for privacy, and Trex Surroundings fencing that uses traditional pickets. Further, it provides TrexTrim product, a cellular PVC residential exterior trim product; steel deck framing systems under Trex Elevations name; and Trex DeckLighting, a line of energy-efficient LED dimmable deck lighting, which is designed for use on posts, floors, and steps. Additionally, the company acts as a licensor in various licensing agreements with third parties to manufacture and sell various products, including Trex Outdoor Furniture; Trex RainEscape, an above joist deck drainage system; Trex CustomCurve, an on-site system that allows contractors to heat and bend Trex products; and Trex Pergolas, a cellular PVC trim product. The company sells its products through wholesale distributors, retail lumber dealers, and Home Depot and Lowe?s stores. Trex Company, Inc. was founded in 1996 and is headquartered in Winc hester, Virginia.
Advisors' Opinion:- [By Rick Munarriz]
Then we have Trex (NYSE: TREX ) and Lumber Liquidators (NYSE: LL ) , the wood-alternative decking and hardwood-flooring retailers that posted double-digit revenue growth in their most recent quarters. Yes, those stocks trade at slightly higher multiples, but in this video longtime Fool contributor Rick Munarriz explains why they are worth it and why it might be time to trade in the orange aprons for a better alternative to both Lowe's and Home Depot stock.
Best Performing Companies To Invest In Right Now: World Wrestling Entertainment Inc.(WWE)
World Wrestling Entertainment, Inc., an integrated media and entertainment company, engages in the sports entertainment business. The company develops content centered around its talent, and presents at its live and televised events featuring World Wrestling Entertainment. It operates through four segments: Live and Televised Entertainment, Consumer Products, Digital Media, and WWE Studios. The Live and Televised Entertainment segment conducts live events; produces television shows; sells merchandise at its live events; provides sponsorships, such as various promotional vehicles, including Internet and print advertising, arena signage, on-air announcements, and pay-per-view sponsorships for advertisers; offers television rights; and markets and promotes the storylines associated with pay-per-view events. It also provides WWE Classics On Demand, a subscription video on demand service that offers classic television shows, pay-per-view events, specials, and original programmi ng. This segment distributes its programming in approximately 30 languages and in approximately 145 countries. Its merchandise consists of various WWE-branded products, such as T-shirts, caps, and other novelty items. The Consumer Products segment licenses and sells retail products, including toys, video games, home videos, apparel, and books; and publishes magazines comprising lifestyle publications with native language editions in the UK, Mexico, Greece, and Turkey. The Digital Media segment operates Web sites; provides advertising services; sells merchandise on its Web site at WWEShop Internet storefront; and offers broadband and mobile content. The WWE Studios segment is involved in the distribution of entertainment films. This segment focuses on creating a mix of filmed entertainment. The company was founded in 1980 and is based in Stamford, Connecticut.
Advisors' Opinion:- [By Bloomberg]
To spark a bidding contest for World Wrestling Entertainment Inc. (WWE), all Vince McMahon needs to do is wave a "for sale" sign. McMahon, 68, controls the voting power of the $2.3 billion company that's been entertaining spectators with staged fights for decades. The stock is at a record after WWE launched its own subscription streaming network and became the subject of takeover speculation. Should McMahon ever decide he's ready to sell, companies from Comcast Corp. (CMCSA) to Madison Square Garden Co. (MSG) may line up with offers, Albert Fried & Co. and National Alliance Capital Markets said. "What is McMahon's succession plan and who will he pass the keys of the kingdom to?" Robert Routh, an analyst at National Alliance, said in a phone interview. "WWE would be very attractive to many different types of buyers. What they've built can't be recreated. But without McMahon's blessing, it doesn't matter how much somebody is willing to pay for the company." The franchise that thrust Hulk Hogan and The Rock into stardom owns the television shows "Raw" and "Smackdown," which have a dedicated following and command high cable-TV ratings, Vertical Group said. The company, which is hosting its annual WrestleMania event in three weeks, will post its best revenue and profit growth in more than a decade next year, according to analysts' estimates compiled by Bloomberg. Stock Surge The stock has climbed 35 percent this month, in part because of takeover speculation, to close at $30.94 last week. WWE isn't in merger talks, Chief Financial Officer George Barrios said in an interview March 6. A representative for the Stamford, Connecticut-based company, declined to comment last week beyond Barrios' earlier statement. WWE's programs, which air on Comcast's USA and SyFy cable networks, may find a new home by the end of April, Barrios said. He said the company is in discussions on future domestic TV distribution with "multiple parties." It has held distribution tal
- [By Eric Volkman]
World Wrestling Entertainment (NYSE: WWE ) has elected to maintain its dividend. The company declared a quarterly distribution of $0.12 per share of both its class A and B common stock, to be paid on Sept. 25 to shareholders of record as of Sept. 13. That amount matches each of the company's previous distributions stretching back to June 2011. Before that, it paid out considerably more at $0.36 per share.
- [By Jon C. Ogg]
Vince McMahon has built World Wrestling Entertainment Inc. (NYSE: WWE) into global wrestling empire over the years. The company recently launched the WWE Network. The network, which had 667,000 as of April, seems well on its way to reaching its stated goal of 1 million subscribers by the end of this year. Despite some concerns about a shift to online viewing and away from live events and pay-per-view, WWE has managed to steadily grow its revenues. Sales were $508 million in 2013, versus $478 million in 2010. The WWE Network is expected to grow revenues to $581 million in 2014 and to nearly $800 million in 2015. In addition to the network, WWE also hosts Wrestlemania ��the professional wrestling's equivalent of the Super Bowl. Its investors currently receive a 2.8% dividend yield.
Best Performing Companies To Invest In Right Now: iMD Companies Inc (ICBU)
IMD Companies, Inc., formerly Optimum Mobile Imaging, Corp, incorporated in 1993, is focused on products and services in the health and fitness nutraceutical and medical diagnostics services markets. The Company provides mobile Ultrasound imaging services. It also provides Echocardiography and Vascular Ultrasound services, including Carotid, Arterial with ABI (ankle-brachial index) and Venous duplex ultrasound. The equipment will be transported into customer's facility on a medical cart by its technologist who will perform all tests in one of customer's exam rooms. In February 2011, the Company completed the acquisition of Integrated Medical Diagnostics, Inc. In January 2014, the Company announced that it has formed a partnership with Anything Technologies Media Inc. by acquiring 51% interest in R-Quest Hydroponics, Inc., developer of the environmental master controller for medical and recreational marijuana hydroponic gardens. In January 2014, IMD Companies Inc and Anything Technologies Media Inc announced that they jointly acquired Green Linx Inc., and will split revenue on a 50:50 basis.
MyLab30 by Biosound implements phased array technology for cardiac imaging, linear array for vascular and small parts imaging, as well as curved array and microconvex for general imaging. The system allows for the evaluation of the heart, vasculature and organs of the body with the appropriate transducer technology and the appropriate measurement and analysis packages.
Advisors' Opinion:- [By Peter Graham]
Small cap marijuana stocks IMD Companies Inc (OTCMKTS: ICBU), Tauriga Sciences Inc (OTCMKTS: TAUG), ML Capital Group Inc (OTCBB: MLCG) and Lexaria Corp (OTCMKTS: LXRP) are aiming to give investors a high with their latest news. However, only one of these small cap marijuana stocks appears to be the subject of minor paid promotion or investor relations type of activities. So will investors and traders alike get a high off of these small caps? Here is a quick reality check:
IMD Companies Inc (OTCMKTS: ICBU) Has a Funding Commitment for Over $1 MillionSmall cap IMD Companies is a Florida corporation, engaged in the medical diagnostics and health and fitness industries. The company is currently positioned to be a holding company for major acquisitions in the medical, and marijuana industry. On Friday, IMD Companies rose 7.82% to $0.120 for a market cap of $19.35 million plus ICBU is up 264.7% over the past year and up 23,900% over the past five years according to Google Finance.
- [By Peter Graham]
Small cap stocks Frontier Beverage Company Inc (OTCMKTS: FBEC), IMD Companies Inc (OTCMKTS: ICBU) and Dmh International Incorporated (OTCBB: DMHI) were all mimicking the Titanic last Friday by sinking 41.18%, 32.5% and 28.16%, respectively, last Friday. Moreover, all three of these stocks have been the subject of paid promotions or investor relation campaigns. With the promotions in mind, is it to late to dump these small cap stocks or will this week present a buying opportunity? Here is a closer look:
No comments:
Post a Comment